SCHEMBL29975560

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)[C@@H](C)CC

nearest known ligand 0.69

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	10/20	0.69

▸	NPY4R	P50391	8/20	0.69

▸	NPY5R	Q15761	8/20	0.69

▸	NPY1R	P25929	8/20	0.69

▸	CALCR	P30988	4/20	0.68

▸	TFPI	P10646	2/20	0.67

▸	F2	P00734	3/20	0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29570760	1.00	NPY2R (0.69)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29571016	0.97	NPY2R (0.70)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29496288	0.92	NPY2R (0.74)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL13248707	0.91	NPY2R (0.80)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30495758	0.91	CALCR (0.72)	NPY2RNPY4RNPY5RNPY1RCALCR
Human Neuropeptide Y SCHEMBL29523348	0.91	CALCR (0.72)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL8816036	0.91	CALCR (0.75)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29872608	0.91	CALCR (0.75)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29496391	0.90	NPY2R (0.72)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29526997	0.90	NPY2R (0.72)	NPY2RNPY4RNPY5RNPY1RCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220241377-A1	RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATES	Molgenie GmbH (DE)	2022-08-04	—	—	US	claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20220241377-A1	RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATES	NPY1R, NPY2R, NPY5R	NPY2R 2/4885NPY4R 4/4885NPY5R 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.